Article
Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer.
Scientific reports - 15 Nov 2024
Zhu Jiamei, Zhang Ting, Jiang Juan, Yang Mei, Xia Nan, Chen Youguo
Abstract excerpt
The study aims to identify potential drug targets for endometrial cancer (EC) subtypes through a Mendelian randomization (MR) approach, assessing their clinical relevance. We utilized genetic instruments for 4,907 plasma proteins from the deCODE Genetics study dataset, and data with EC (n = 12,906) from a genome-wide study (GWAS) meta-analysis in European populations for MR analyses. Complementary analyses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
